Pacira BioSciences
PCRX
PCRX
279 hedge funds and large institutions have $1.48B invested in Pacira BioSciences in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 104 increasing their positions, 76 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $1.44B → $1.48B (+$46.8M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
70% less call options, than puts
Call options by funds: $12.3M | Put options by funds: $40.8M
Holders
279
Holding in Top 10
4
Calls
$12.3M
Puts
$40.8M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$14.7M | |
| 3 | +$13.2M | |
| 4 |
DPCM
Doma Perpetual Capital Management
Miami,
Florida
|
+$11.9M |
| 5 |
Barclays
London,
United Kingdom
|
+$10.3M |
Top Sellers
| 1 | -$34.3M | |
| 2 | -$15.7M | |
| 3 | -$7.7M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$5.54M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$5.32M |